We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+17.44%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$21.2B
AUM Growth
+$9.29B
Cap. Flow
+$6.85B
Cap. Flow %
32.33%
Top 10 Hldgs %
46.61%
Holding
1,745
New
495
Increased
382
Reduced
298
Closed
321

Sector Composition

Rank Sector Weight
1 Financials 7.84%
2 Healthcare 6.33%
3 Technology 4.78%
4 Consumer Staples 2.78%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CABA icon
1226
Cabaletta Bio
CABA
$439M
$111K ﹤0.01%
47,500
-1,949,708
-98% -$3.35M
BRX icon
1227
Brixmor Property Group
BRX
$9.7B
$111K ﹤0.01%
+4,000
New +$107K
CRBU icon
1228
Caribou Biosciences
CRBU
$148M
$110K ﹤0.01%
+47,200
New +$89.1K
VTYX
1229
DELISTED
Ventyx Biosciences
VTYX
$106K ﹤0.01%
+34,100
New +$90.3K
PRAX icon
1230
Praxis Precision Medicines
PRAX
$8.19B
$106K ﹤0.01%
2,000
-3,000
-60% -$145K
TFC icon
1231
PUT
Truist Financial
TFC
$63.9B
$105K ﹤0.01%
+2,300
New +$104K
LCTX icon
1232
Lineage Cell Therapeutics
LCTX
$264M
$105K ﹤0.01%
+62,200
New +$73.6K
AIV
1233
Aimco
AIV
$378M
$105K ﹤0.01%
+13,194
New +$107K
KWEB icon
1234
KraneShares CSI China Internet ETF
KWEB
$5.53B
$104K ﹤0.01%
2,477
-2,747
-53% -$103K
AIFC
1235
AI Financial Corp
AIFC
$51.8M
$102K ﹤0.01%
+38,100
New +$228K
IVVD icon
1236
Invivyd
IVVD
$163M
$102K ﹤0.01%
+92,300
New +$81.9K
TNYA icon
1237
Tenaya Therapeutics
TNYA
$161M
$99.3K ﹤0.01%
+61,300
New +$61.7K
KYTX icon
1238
Kyverna Therapeutics
KYTX
$438M
$97.8K ﹤0.01%
+16,300
New +$65.2K
AMPY icon
1239
Amplify Energy
AMPY
$157M
$96.3K ﹤0.01%
+18,350
New +$72.2K
TVTX icon
1240
Travere Therapeutics
TVTX
$5.26B
$95.6K ﹤0.01%
+4,000
New +$75.2K
SGMT icon
1241
Sagimet Biosciences
SGMT
$441M
$95.4K ﹤0.01%
+13,900
New +$113K
TONX
1242
TON Strategy Co
TONX
$170M
$90.8K ﹤0.01%
+12,900
New +$151K
LPTH icon
1243
Lightpath Technologies
LPTH
$605M
$90.4K ﹤0.01%
+11,400
New +$50.9K
CPRT icon
1244
Copart
CPRT
$28.6B
$89.9K ﹤0.01%
2,000
-26,000
-93% -$1.23M
CORZ icon
1245
CALL
Core Scientific
CORZ
$5.92B
$89.7K ﹤0.01%
5,000
-492,900
-99% -$7.23M
BDTX icon
1246
Black Diamond Therapeutics
BDTX
$97.4M
$86.4K ﹤0.01%
+22,800
New +$66.7K
LUV icon
1247
CALL
Southwest Airlines
LUV
$21.9B
$86.2K ﹤0.01%
+2,700
New +$88.3K
ALIT icon
1248
Alight
ALIT
$539M
$85.2K ﹤0.01%
+1,307
New +$115K
NMRA icon
1249
Neumora Therapeutics
NMRA
$304M
$84.8K ﹤0.01%
+46,600
New +$75.3K
CCCC icon
1250
C4 Therapeutics
CCCC
$400M
$84.8K ﹤0.01%
+38,200
New +$91.7K

Similar funds

Jefferies Financial Group's Q3 2025 Portfolio in Review

As of Q3 2025, Jefferies Financial Group held 1,745 positions worth $21.2B, up 78% from $11.9B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Jefferies Financial Group deployed $6.85B of net new capital in Q3 2025, opening 495 new positions and adding to 382 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 18,000,000 shares worth $1.68B.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $147M trimmed.

  • Jefferies Financial Group's largest Q3 2025 buy was Vanguard Information Technology ETF: 18,000,000 shares worth $1.68B.
  • Jefferies Financial Group added most to Costco in Q3 2025, an estimated $226M increase.
  • Jefferies Financial Group's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $147M.
  • Jefferies Financial Group fully exited Take-Two Interactive in Q3 2025, selling an estimated $51.2M.
  • Jefferies Financial Group's ten largest holdings make up 47% of its $21.2B portfolio in Q3 2025.
  • Jefferies Financial Group opened 495 new positions and closed 321 in Q3 2025.
  • Jefferies Financial Group's portfolio value rose 78% quarter-over-quarter to $21.2B.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.